TrialAnnals of oncology : official journal of the European Society for Medical Oncology2018

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.

M J Overman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.